| 000 | 01894nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025912.0 | ||
| 008 | 090720s2009 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.04.Ph.D.2009.Ha.C | ||
| 100 | 0 | _aHala Bakr Ali Elnassan | |
| 245 | 1 | 0 |
_aComputer-based drug design and synthesis of certain pyrazolopyrimidine and bis(pyrimidinyI) methane derivatives as potential antineoplastic agents / _cHala Bakr Ali Elnassan ; Supervised Mervat Mostafa Elenany , Mona Monir Kamel , Omneya Mahmoud Khalil |
| 246 | 1 | 5 | _aتصميم وتشييد بعض مشتقات من البيرازولوبيريميدين وثنائى بيريميدنيل ميثان كمضادات للاورام السرطانية |
| 260 |
_aCairo : _bHala Bakr Ali Elnassan , _c2009 |
||
| 300 |
_a132P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Organic chemistry | ||
| 520 | _aThe study comprises a survey on the cyclin dependent kinases(CDKs) and their inhibtors.The thesis involves the design docking study and synthesis of some pyrazolo[3,4-d] pyrimidin-4-one,pyrazolo[1,5-a] pyrimidine and bis(6-aminopyrimidin-5-y1) (substituted pheny1) methane derivatives as CDK2 inhibitors to be investigated as new antineoplastic agents | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAntineoplastic activity | |
| 653 | 4 | _aBis(6-aminopyrimidin-5-y1) (substituted pheny1) methane | |
| 653 | 4 | _aPyrazolo[3,4-d] pyrimidin-4-one | |
| 700 | 0 |
_aMervat Mostafa Elenany , _eSupervisor |
|
| 700 | 0 |
_aMona Monir Kamel , _eSupervisor |
|
| 700 | 0 |
_aOmneya Mahmoud Khalil , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c23175 _d23175 |
||